Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
NYSE MKT:PLX
Holding PLX?
Track your performance easily
Protalix (PLX) Ownership Overview
4.29% Insiders
0.63% Mutual Funds
0.93% Other Institutional Investors
0.23% ETFs
93.93% Public Companies and
Individual Investors
The ownership structure of Protalix (PLX) stock is a mix of institutional, retail, and individual investors. Approximately 1.78% of the company’s stock is owned by Institutional Investors, 4.29% is owned by Insiders, and 93.93% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,281,934 | Insider | 3.10% | 4,107,481 | |
| 669,010 | Insider | 0.91% | 1,204,218 | |
| 251,019 | Institution | 0.34% | 451,834 | |
| 207,929 | Insider | 0.28% | 374,272 | |
| 180,000 | Institution | 0.24% | 324,000 | |
| 166,062 | Institution | 0.23% | 298,912 | |
| 23,784 | Institution | 0.03% | 42,811 | |
| 5,657 | Institution | <0.01% | 10,183 | |
| 640 | Institution | <0.01% | 1,152 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 251,019 | Institution | 0.34% | 451,834 | |
| 180,000 | Institution | 0.24% | 324,000 | |
| 23,784 | Institution | 0.03% | 42,811 | |
| 5,657 | Institution | <0.01% | 10,183 | |
| 640 | Institution | <0.01% | 1,152 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 166,062 | Institution | 0.23% | 298,912 |
FAQ
Who Owns Protalix Biotherapeutics (PLX)?
According to the latest TipRanks data, approximately 0.93% of the company's stock is held by institutional investors, 4.29% is held by insiders, and 93.93% is held by retail investors.
What percentage of Protalix Biotherapeutics (PLX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.93% of Protalix Biotherapeutics (PLX) stock is held by institutional investors.
What percentage of Protalix Biotherapeutics (PLX) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.93% of Protalix Biotherapeutics (PLX) stock is held by retail investors.
Who owns the most shares of Protalix Biotherapeutics (PLX)?
Dror Bashan owns the most shares of Protalix Biotherapeutics (PLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.